MARKET

BCPC

BCPC

Balchem Corp
NASDAQ
180.02
+5.21
+2.98%
Opening 15:19 07/26 EDT
OPEN
178.53
PREV CLOSE
174.81
HIGH
182.01
LOW
172.58
VOLUME
88.09K
TURNOVER
0
52 WEEK HIGH
182.01
52 WEEK LOW
110.14
MARKET CAP
5.84B
P/E (TTM)
50.96
1D
5D
1M
3M
1Y
5Y
1D
BCPC Stock Earnings: Balchem Beats EPS, Misses Revenue for Q2 2024
Balchem reported earnings per share of $1.09 for the second quarter of 2024. The company reported revenue of $234.08 million. Balchem's revenue was 2.34% lower than the analyst estimate for the same period. The stock is down 2.7% this morning.
Investorplace · 10h ago
Blachem (BCPC) Tops Q2 Earnings Estimates
NASDAQ · 13h ago
Balchem Non-GAAP EPS of $1.09 beats by $0.06, revenue of $234.08M misses by $5.61M
Seeking Alpha · 15h ago
Balchem Q2 Adj $1.09 Beats $1.03 Estimate, Sales $234.08M Miss $239.69M Estimate
Balchem reported quarterly earnings of $1.09 per share. The company reported quarterly sales of $234.08 million. Balchem beat the analyst consensus estimate of $239.69 million by 2.34%. The company's sales for the same period last year were $231.25 million.
Benzinga · 15h ago
BRIEF-Balchem Q2 EPS USD 0.98
Reuters · 15h ago
Balchem Corporation Reports Second Quarter 2024 Financial Results
Balchem Corporation reported financial results for its 2024 fiscal second quarter ended June 30, 2024. The Company reported quarterly net sales of $234.1 million and quarterly net earnings of $32.2 million. Balchem reported quarterly free cash flow of $38.4 million.
Barchart · 20h ago
Notable earnings before Friday's open
Major earnings expected before the bell on Friday include: Bristol-Myers Squibb, Colgate-Palmolive, 3M, Oxford Lane Capital, T. Rowe Price Group. Notable earnings before Friday's open include: BMY, CL, MMM, GNTX.
Seeking Alpha · 1d ago
Weekly Report: what happened at BCPC last week (0715-0719)?
Weekly Report · 4d ago
More
About BCPC
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.

Webull offers Balchem Corp stock information, including NASDAQ: BCPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCPC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCPC stock methods without spending real money on the virtual paper trading platform.